Carregant...
The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications
BACKGROUND: Translating prognostic and diagnostic biomarker candidates into clinical applications takes time, is very costly, and many candidates fail. It is therefore crucial to be able to select those biomarker candidates that have the highest chance of successfully being adopted in the clinic. Th...
Guardat en:
| Publicat a: | Cost Eff Resour Alloc |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006586/ https://ncbi.nlm.nih.gov/pubmed/29946228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-018-0105-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|